The World Health Organization’s decision to stick with a 14-day quarantine for the novel coronavirus, announced February 12, 2020, leaves a Chinese study with a 24-day incubation figure in limbo. That study, posted on the preprint server medRxiv, is not peer-reviewed. The platform itself warns its contents should not guide clinical practice. Yet the paper, led by prominent epidemiologist Zhong Nanshan, has already circulated widely, stirring public confusion and raising questions about how authorities communicate uncertain science during a fast-moving outbreak.
The study analyzed 1,099 patients across China. It found a median incubation period of three days. The range stretched from zero to 24 days. That extreme outlier is what caught attention. Dr. Michael Ryan, executive director of WHO’s Health Emergencies Programme, told reporters that long incubation periods in other diseases, like Ebola, often come from double exposures — not a single infection. He said the 24-day data point needs more review and more evidence before any policy shift. The WHO will not change its guidance.
The practical fallout is immediate. Hundreds of thousands of people under quarantine in China and elsewhere are watching the clock. A 14-day period is already a burden on individuals, families, and supply chains. Extending it to 24 days would have doubled the strain on medical monitoring, food delivery, and psychological endurance. Employers face longer worker absences. Governments must stockpile more masks, gloves, and test kits. The WHO’s refusal to extend keeps those pressures contained — for now.
But the study itself is not dead. It remains on medRxiv, open for other researchers to critique, replicate, or refine. The scientific process will grind on. Other teams may publish their own incubation data in peer-reviewed journals. If multiple studies confirm a longer maximum incubation, the WHO could revisit its position. That would take weeks, not days. In the meantime, public health officials must explain why a 24-day figure exists in a preprint but does not change what people on the ground should do.
Trust is a fragile thing in a pandemic. The WHO’s clear rejection of the Chinese researchers’ suggestion may reassure some that decisions are based on evidence, not panic. But it also risks looking like a dismissal of Chinese science — a sensitive issue given the outbreak’s origin in Wuhan. Zhong Nanshan is a respected figure in China, known for his work on SARS. His study was not officially published; it was a preprint. Yet its release on a public server meant it was immediately picked up by news outlets, creating a wave of anxiety that the WHO then had to counter.
What happens next depends on data. If more cases emerge with incubation periods beyond 14 days, and if those cases are clearly linked to single exposures, the WHO will face pressure to adjust. For now, Dr. Ryan’s caution stands. Double exposures are a real possibility. Until that is ruled out, the 14-day quarantine remains the rule. Travel restrictions, border screenings, and workplace policies all hinge on that number. A change would ripple across every country trying to contain the virus. The WHO chose stability over speculation.
